Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements Meeting Abstract


Authors: Siena, S.; Drilon, A. E.; Ou, I. S. H.; Farago, A. F.; Patel, M.; Bauer, T. M.; Hong, D.; Liu, S. V.; Lee, J.; Patel, R.; Schechet, L.; Luo, D.; Maneval, E. C.; Multani, P. S.; De Braud, F. G.
Abstract Title: Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S724
End Page: S725
Language: English
ACCESSION: WOS:000361887403280
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)31947-5
Notes: Meeting Abstract: 29LBA -- Source: Wos
Altmetric Score
MSK Authors
  1. Alexander Edward Drilon
    136 Drilon